NCT02304484 Open-label Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab Status COMPLETED Phase PHASE3
NCT02289963 Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan Status COMPLETED Phase PHASE3
NCT02288585 The Effect of Plant Sterols on the Blood Lipid Profile of Subjects With and at High Risk of Type 2 Diabetes Mellitus Status COMPLETED Phase NA
NCT02260648 A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia Status TERMINATED Phase PHASE3
NCT02260635 A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary Hypercholesterolemia Status TERMINATED Phase PHASE3
NCT02251847 The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients Status UNKNOWN Phase PHASE3
NCT02221297 Lipid-lowering Effect of a Plant Stanol Ester Supplement Product Status COMPLETED Phase NA
NCT02216825 Effect of L. Reuteri NCIMB 30242 on Plasma Bile Acid Profile Status COMPLETED Phase PHASE2
NCT02178098 Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension Status COMPLETED Phase PHASE2
NCT02107898 Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN) Status COMPLETED Phase PHASE3
NCT02100839 Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia Status COMPLETED Phase PHASE1/PHASE2
NCT02091024 Blood Lipid-lowering Effect of Brown Alga Ecklonia Cava Status COMPLETED Phase PHASE2/PHASE3
NCT02078167 Long Term Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols and Berberine) in Low-moderate Risk Hypercholesterolemic Patients: a Double-blind, Placebo Controlled Study Status COMPLETED Phase PHASE4
NCT02072161 Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy Status COMPLETED Phase PHASE2
NCT02065024 Food Matrix and Genetic Variability as Determinants of Bioavailability and Biological Effects of Beta-cryptoxanthin and Phytosterols Status COMPLETED Phase PHASE1